CPM-29317-44200
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 1 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
-
2021-05-12
Dose 2 — Pfizer-BioNTech
- 2021-05-12
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-18
- 2021-05-19
- 2021-05-26
-
2021-06-02
Survey response — day 21, dose 2MedDRA: Oropharyngeal pain, Sneezing — Feeling: FairFree text: Sore throat, sneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-11
- 2021-06-16
- 2021-06-23
-
2021-08-13
Survey response — 3 months, dose 2MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Congestion, sore throat, coughMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-10
-
2021-11-17
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-02-17
- 2022-05-18
-
2022-11-17
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory syncytial virus test positive, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for RSV. Sore throat, cough, congestion, runny nose, sneezing.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-18
- 2022-11-21
-
2022-11-21
Callback requested for04:15PM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-21 | Pfizer-BioNTech | |
| 2 | 2021-05-12 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 21, dose 2
Symptoms: Sore throat, sneezing
Release 9 — 3 months, dose 2
Symptoms: Congestion, sore throat, cough
Release 12 — 12 months, dose 3
Symptoms: Tested positive for RSV. Sore throat, cough, congestion, runny nose, sneezing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus test positive | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release